CN Stock MarketDetailed Quotes

688621 Beijing Sun-Novo Pharmaceutical Research

Watchlist
  • 51.93
  • -0.82-1.55%
Market Closed May 17 15:00 CST
5.82BMarket Cap27.76P/E (TTM)

About Beijing Sun-Novo Pharmaceutical Research Company

The company was founded in 2009 and is one of the first CRO companies in China to provide drug research and development services to the outside world. The company's main business covers comprehensive R&D services in innovative drug development, generic drug development and consistency evaluation. The company's products mainly include drug discovery, pharmacological efficacy, pharmaceutical research, clinical research and biological analysis. The company's corporate honors include: Beijing Enterprise Technology Center, Beijing Enterprise Science and Technology Research and Development Agency 2020, Chengdu High-tech Zone Seed Stage Young Eagle Enterprise 2019, China's Top 20 Pharmaceutical Research and Development 2019, etc.

Company Profile

Short Name-A阳光诺和
Company NameBeijing Sun-Novo Pharmaceutical Research Co.,Ltd.
Listing DateJun 21, 2021
Issue Price26.89
Shares Offered20.00M share(s)
FoundedMar 9, 2009
Chairmanqian li
Legal Representativeyujing liu
General Manageryujing liu
Secretarylingyang zhao
Employees1370
ProvinceBei Jing Shi
Phone010-60748199
Office Address1st Floor, Building 7, No. 79, Shuangying West Road, Science and Technology Park, Changping District, Beijing
Zip Code102200
Registered Address1st Floor, Building 7, No. 79, Shuangying West Road, Science and Technology Park, Changping District, Beijing
Fax010-60748199
Emailir@sun-novo.com
Business License91110107685771683F
BusinessThe company's main business is to provide specialized R&D outsourcing services for pharmaceutical companies, covering comprehensive R&D services in generic drug development, consistency evaluation, and innovative drug development. The services mainly include pharmaceutical research, clinical trials, and bioanalysis.

Company Executives

  • Name
  • Position
  • Salary
  • qian li
  • Chairman,directors
  • 1.50M
  • yujing liu
  • directors,general manager
  • 2.25M
  • ying zhang
  • directors
  • --
  • wenran li
  • directors
  • --
  • lingyang zhao
  • directors,Board Secretary,Chief Financial Officer
  • 1.04M
  • qiao chen
  • directors
  • --
  • zhuangkun he
  • Independent directors
  • 120.00K
  • xian shi
  • Independent directors
  • 90.00K
  • huiting zhu
  • Independent directors,Nomination Committee Members,Strategy Committee Members,Audit Committee Members
  • --
  • liping wei
  • Securities affairs representative
  • --
  • dandan wang
  • Chairman of the Supervisory Board,auditors
  • 743.12K
  • zhen zhou
  • auditors
  • 302.16K
  • huan luo
  • Deputy General Manager,Core technical personnel
  • 1.32M
  • yan shao
  • Deputy General Manager
  • 1.16M
  • guangtao hao
  • Deputy General Manager,Core technical personnel
  • 1.11M
  • guangpeng meng
  • Core technical personnel
  • 364.65K
  • yuanbo li
  • Core technical personnel
  • 938.21K
  • mingjuan wang
  • Core technical personnel
  • 461.86K
  • yuanfeng tong
  • Core technical personnel
  • 1.00M
  • yu yuan
  • Core technical personnel
  • 836.85K
  • daosheng xie
  • Core technical personnel
  • 1.06M
  • jinfeng zhang
  • Employee supervisors
  • 3.80M

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg